| Metric | FY 2021 | Prior Q | FY 2020 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $309M | — | $291M | — | 6.1% |
| Op. Income | $152M | — | $119M | — | 27.8% |
| Gross Margin | 94.2% | — | 81.5% | — | 12.8pp |
| Net Margin | 35.5% | — | 29.0% | — | 6.5pp |
| EPS (Diluted) | $2.41 | — | $1.88 | — | 28.2% |
| Free Cash Flow | $94M | — | $65M | — | 45.1% |
| Item | Amount |
|---|---|
| REVENUE | $309M |
| Cost of Revenue | $18M |
| GROSS PROFIT | $291M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $88M |
| SG&A Expenses | $88M |
| Other Expenses | $51M |
| Operating Expenses | $139M |
| Cost & Expenses | $157M |
| OPERATING INCOME | $152M |
| Interest Income | $247M |
| Interest Expense | $14M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $152M |
| Income Tax Expense | $42M |
| Net Income from Continuing Ops | $110M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $110M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $110M |
| D&A | $7M |
| EBIT | $152M |
| EBITDA | $159M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| REVENUE | $309M |
| Cost of Revenue | $18M |
| GROSS PROFIT | $291M |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $88M |
| SG&A Expenses | $88M |
| Other Expenses | $51M |
| Operating Expenses | $139M |
| Cost & Expenses | $157M |
| OPERATING INCOME | $152M |
| Interest Income | $247M |
| Interest Expense | $14M |
| Other Income/Expenses | $0 |
| INCOME BEFORE TAX | $152M |
| Income Tax Expense | $42M |
| Net Income from Continuing Ops | $110M |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $110M |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $110M |
| D&A | $7M |
| EBIT | $152M |
| EBITDA | $159M |
| EPS | $2 |
| EPS Diluted | $2 |
| Item | Amount |
|---|---|
| Net Income | $110M |
| Depreciation & Amortization | $7M |
| Stock-Based Compensation | $3M |
| Deferred Income Tax | -$2M |
| Other Non-Cash Items | -$5M |
| Change in Working Capital | -$16M |
| OPERATING CASH FLOW | $97M |
| Capital Expenditure | -$3M |
| Acquisitions (Net) | $1.1B |
| Purchases of Investments | -$455M |
| Sales/Maturities of Investments | $272M |
| Other Investing Activities | -$1.0B |
| NET CASH FROM INVESTING | -$79M |
| Net Debt Issuance | -$238M |
| Common Stock Repurchased | -$2M |
| Common Dividends Paid | -$16M |
| Other Financing Activities | $728M |
| NET CASH FROM FINANCING | $474M |
| FREE CASH FLOW | $94M |
| Net Change in Cash | $492M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $1.1B |
| Short-Term Investments | $1.2B |
| Net Receivables | $0 |
| Inventory | $0 |
| Other Current Assets | $0 |
| TOTAL CURRENT ASSETS | $2.3B |
| PP&E (Net) | $38M |
| Goodwill | $0 |
| Intangible Assets | $222M |
| Long-Term Investments | $7.4B |
| Tax Assets | $21M |
| Other Non-Current Assets | $228M |
| TOTAL NON-CURRENT ASSETS | $7.9B |
| TOTAL ASSETS | $10.2B |
| Account Payables | $110M |
| Short-Term Debt | $173M |
| Deferred Revenue | $0 |
| Other Current Liabilities | $8.6B |
| TOTAL CURRENT LIABILITIES | $8.9B |
| Long-Term Debt | $210M |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $0 |
| Other Non-Current Liabilities | $0 |
| TOTAL NON-CURRENT LIABILITIES | $210M |
| TOTAL LIABILITIES | $9.1B |
| Common Stock | $56.0K |
| Additional Paid-In Capital | $721M |
| Retained Earnings | $341M |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $2M |
| Other Equity | $0 |
| TOTAL STOCKHOLDERS' EQUITY | $1.1B |
| Minority Interest | $0 |
| TOTAL EQUITY | $1.1B |
| TOTAL LIABILITIES & EQUITY | $10.2B |
| Total Debt | $210M |
| Net Debt | -$912M |